Rachid ELJAOUDI, Naoual ELOMRI, Meryem LAAMARTI, Yahia CHERRAH, Taoufik AMEZYANE, Driss GHAFIR, Azeddine IBRAHIMI

Antioxidants status in type 2 diabetic patients in Morocco

Background/aim: Type 2 diabetes is a heterogeneous and multifactorial metabolic disorder with some relationship to oxidative stress (OS). Since no studies were conducted in the Moroccan population, this clinical investigation aimed at evaluating the antioxidants status in Moroccan patients with type 2 diabetes. Materials and methods: Blood samples of 60 type 2 diabetic patients and 40 healthy controls subjects were analyzed for determination of glycemia, hemoglobin, CRP, glycated hemoglobin, lipid parameters, malondialdehyde (MDA), vitamins E and C, copper (Cu), zinc (Zn), and selenium (Se). Results: CRP and triglycerides were higher in the diabetic group while high-density lipoprotein levels were significantly lower compared to the control group. Plasma MDA, Cu concentrations, and Cu/Zn ratio were found to be higher in diabetic patients compared to healthy subjects, while vitamin E, Zn, and Se concentrations were lower compared to the control group. No significant difference was found in vitamin C levels between the two groups. Plasma HbA1c was positively correlated to MDA levels. Conclusion: This study shows that antioxidant status is impaired in diabetics compared to healthy controls.

PDF

___

1. Ovalle F, Garvey WT. Type 2 diabetes mellitus. In: Martini L, Burlington MA, editors. Encyclopedia of endocrine diseases. Burlington, MA, USA: Academic Press/Elsevier Science, 2004, pp. 546-566.
2. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012: 1-30.
3. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontology 2007; 44: 127-153.
4. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetes vascular disease. Bratisl Lek Listy 2000; 101: 541-551.
5. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetes complications. Sultan Qaboos Univ J 2012; 12: 5-18.
6. Mohora M, Greabu M, Muscurel C, Duta C, Totan A. The sources and the targets of oxidative stress in the etiology of diabetes complications. Romanian J Biophys 2007; 17: 63-84.
7. Small DM, Coombes JS, Bennett N, Johnson DW, Gob GC. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology 2012; 17: 311-321.
8. Kassab A, Piwowar A. Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 2012; 94: 1837- 1848.
9. Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann NY Acad Sci 2004; 1011: 168-176.
10. Giacco F, Brownlee M. Oxidative stress and diabetes complications. Circ Res 2010; 107: 1058-1070.
11. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with micro vascular complications. Open Endocrinol J 2009; 3: 12-15.
12. Quilliot D, Walters E, Bonte JP, Fruchart JC, Duriez P, Ziegler O. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am J Clin Nutr 2005; 81: 1117-1125.
13. Kaur B, Henry J. Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res 2014; 71: 55-100.
14. Fukunaga K, Yoshida M, Nakazono N. A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed Chromatogr 1998; 12: 300-303.
15. Shen GX. Oxidative stress and diabetes cardiovascular disorders: roles of mitochondria and NADPH oxidase. Can J Physiol Pharmacol 2010; 88: 241-248.
16. Pan HZ, Zhang L, Guo MY, Sui H, Wu WH, Qu NQ, Liang MH, Chang D. The oxidative stress status in diabetes mellitus and diabetes nephropathy. Acta Diabetol 2010; 47: 71-76.
17. Ola MS, Berkich DA, Xu Y, King MT, Gardner TW, Simpson I, LaNoue KF. Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 2006; 290: E1057- 1067.
18. Rafighi Z, Shiva A, Arab S, Yusuf RM. Association of dietary vitamin C and E intake and antioxidant enzymes in type 2 diabetes mellitus patients. Global Journal of Health Science 2013; 3: 183-187.
19. Armstrong A, Chesnutt JE, Gormley MJ, Young IS. The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin dependent diabetes. Free Radic Biol Med 1996; 21: 719-726.
20. Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomized study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabetes Med 2001; 18: 756-760.
21. Bjelakovic G. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842-857.
22. Devaraj S, Jialal I. The effects of alpha-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 1998; 9: 11-15.
23. Upritchard JE, Sutherl WHF, Mann JI. Effect of supplementation, vitamin E and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2008; 23: 733-738.
24. Afkhami-Ardekani M, Mohiti, J, Amirchaghmaghi E, Modarresi M. The effect of vitamins C and E supplementation on insulin level, HbA1C and blood glucose in type 2 diabetic patients. J Beh Kerm Univ Med Sci 2009; 11: 12-18.
25. Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO. High-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006; 290: 137-145.
26. Dean PJ. Redefining oxidative stress. Antioxidants and Redox Signaling 2006; 8: 1865-1879.
27. Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biological Trace Element Research 2001; 79: 205-219.
28. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biological Trace Element Research 2008; 122: 1-18.
29. Siddiqui K, Bawazeer N, Joy SS. Variation in macro and trace elements in progression of type 2 diabetes. Scientific World Journal 2014; 2014: 461591.
30. Xu J, Zhou Q, Liu G, Tan Y, Cai L. Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxid Med Cell Longev 2013; 2013: 635214.
31. Roxboroug HE, Millar CA, McEneny J, Young IS. Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Biochem Biophysical Res Commun 1995; 214: 1073-1078.
32. Ma GC, Wu PF, Tseng HC, Chyau CC, Lu HC, Chou FP. Inhibitory effect of Piper betel leaf extracts on copper-mediated LDL oxidation and oxLDL-induced lipid accumulation via inducing reverse cholesterol transport in macrophages. Food Chem 2013; 141: 3703-3713.
33. Fields M, Ferretti RJ, Smith JC Jr, Reiser S. Effect of copper deficiency on metabolism and mortality in rats fed sucrose or starch diets. J Nutr 1983; 113: 1335-1345.
34. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. Journal of Nutrition 2001; 131: 1414-1420.
35. Kelly F. Use of antioxidants in the prevention and treatment of disease. Journal of the International Federation of Clinical Chemistry 1998; 10: 21-23.
36. Salgueiro MJ, Krebs N, Zubillaga MB, Weill R, Postaire E, Lysionek AE, Caro RA, De Paoli T, Hager A, Boccio J. Zinc and diabetes mellitus: is there a need of zinc supplementation in diabetes mellitus patients? Biological Trace Element Research 2001; 81: 215-228.
37. Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 2011; 44: 275-280.
38. Rayman MP. Selenium and human health. Lancet 2012; 379: 1256-1268.
39. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, State EH, Fischbac LA, Marshall JR, Clark LC. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630-639.
40. Ruiz C, Algeria A, Barbera R, Farre R, Lagarda MJ: Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol1998, 12: 91-95.
41. Sedighi O, Makhlough A, Shokrzadeh M, Hoorshad S. Association between plasma selenium and glutathione peroxidase levels and severity of diabetic nephropathy in patients with type two diabetes mellitus. Nephro Urol Mon 2014; 5: e21355.
42. Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 2005; 24: 250-256.
43. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 20032004. Environ Health Perspect 2009; 117: 1409-1413.
44. Lockitch G. Selenium: clinical significance and analytical concepts. Crit Rev Clin Lab Sci 1989; 27: 483-541.
45. Diplock AT: Antioxidant nutrients and disease prevention: an overview. Am J Chim Nutr 1991; 53: 1895-1935.
46. Moussa SA. Oxidative stress in diabetes mellitus. Romanian J Biophys 2008; 18: 225-336.
47. Cabrales P, Salazar Vázquez MA, Salazar Vázquez B, RodríguezMorán M, Intaglietta M, Guerrero-Romeros F. Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients. Vasc Heal Risk Manag 2008; 4: 917-922.
48. Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK. Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med 2011; 2: 107-112.
49. Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes 2015; 39: 44-49.
50. Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002; 25: 69-76.